Condition: Aortic Stenosis · Aortic Stenosis, Severe · Sponsor: Edwards Lifesciences
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic bioprosthetic valve.
This description comes directly from the study's public registry record.
Edwards THV Clinical Affairs · (949) 250-2500 · THV_CT.gov@Edwards.com
Always discuss trial participation with your own doctor first.
| Banner University Medical Center | Phoenix, Arizona, United States | Recruiting |
| University of California Los Angeles | Los Angeles, California, United States | Recruiting |
| Sutter Medical Center | Sacramento, California, United States | Recruiting |
| Kaiser Permanente San Francisco | San Francisco, California, United States | Withdrawn |
| Stanford University Medical Center | Stanford, California, United States | Recruiting |
| UC Health Northern Colorado/Medical Center of the Rockies | Loveland, Colorado, United States | Recruiting |
| Hartford Hospital | Hartford, Connecticut, United States | Recruiting |
| JFK Medical Center/ Atlantic Clinical Research Collaborative | Atlantis, Florida, United States | Withdrawn |
| University of Florida, Gainesville | Gainesville, Florida, United States | Withdrawn |
| Emory University Hospital | Atlanta, Georgia, United States | Recruiting |
| Northwestern University Hospital | Chicago, Illinois, United States | Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Recruiting |
+ 39 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.